Download our Prostate Cancer Landscape Assessment
Explore the role of emerging diagnostic techniques in Prostate Cancer
Summary of our landscape review and the full report available to download here
Prostate cancer remains a leading cause of cancer deaths in men worldwide. However, new diagnostic, management and therapeutic approaches provide opportunities to change this landscape.
To stay on top of the latest innovations, our teams recently performed both qualitative and quantitative research with leading prostate cancer specialists. These invaluable insights provide a unique view of the real challenges HCPs and pharma face in delivering improved outcomes to patients and are summarised in our latest landscape analysis review.
In this landscape analysis, we explore the role of emerging diagnostic techniques such as prostate-specific membrane antigen positron emission tomography (PSMA PET) and targeted therapies, such as PSMA radioligands, poly ADP ribose polymerase (PARP) inhibitors, immunotherapies, and combination regimens.
